Trading updates:

DNDN had HUGE volume on the 3rd of July (which was a shortened trading session). Expect the same thing today. As of this writing at 9am on the 5th, over 300K shares have traded in pre-market. The driver of the recent action is a study by leading Cancer researchers that suggests immuno-therapeutic cancer treatments, like Provenge, do seem to increase patient survivability. They also stated that such treatments which rely upon using the patient's own immune system to fight the cancer, require more time to work, thus patient studies should be adjusted by the FDA to take this fact into account.

But most of all, CNBC's "Fast Money" noted the extreme call option activity in the stock:

"Fast Money" calls DNDN a potential lottery ticket

In my opinion, with over 40% of the stock float (tradeable public shares) short, this represents a tremendous potential for gains of 50-100% in this stock. The SEC is cracking down on "naked short selling" and DNDN's shares have been on the SEC's Reg SHO list for months now:

Reg SHO list

Now.. some of my other positions. QTWW experienced a significant "downdraft" as it was removed from the Russell 3000 index and their placement of $18 million in shares at 1.50. But it remains in an uptrend channel:

QTWW charts for 5 July

Rumours also seem to abound that FRPT will receive a huge multi-billion order from the military for their Cheetah MRAP vehicles, and this could provide some support for QTWW, as they have some engineering associations with FRPT.

Furthermore, it would appear that GM is planning on focusing on Fuel Cell vehicles, and that would definitely play into QTWW's benefit.

GM prioritizing alternative energy vehicles

I'm expecting a rebound in QTWW to at least $2/share as a retest of resistance. But to penetrate that price, it will require some positive news, IMO.

NOW... I wanted to update the activity in CCUR. I ran the charts today and what I'm seeing is probably one of the most bullish TA "Grand Alignments" I've ever witnessed. Every chart, hourly, daily, weekly, monthly, quarterly, has turned positive for CCUR. Now all that is required is substantial positive news, and volume and the shares could easily rally to $3-4/share short-term..

Don't believe me? Check it out for yourself:

CCUR charts for 5 July

Be sure to imput the monthly and quarterly time frames into the charts to observe long term trend.

Finally.. GNBT..

GNBT is at an inflection point. If it breaks below current price levels, it will face some difficulties short term. The stock requires news and volume in order to move higher and hopefully we'll see this sometime this week. R&R has reiterated a $6/share target, citing increased interest in Oral-Lyn as a result of GNBT's presentations at the ADA conference a few weeks ago:

GNBT charts for 5 July

I'm also starting to research and review BCON, and I'm also starting to get re-interested in MVIS (but I need to see that stock stabilize). Also, INAP is looking like it's trying to find a bottom here as well, but I expect some churning of the shares over the short term in order to rehabilitate the chart:

INAP daily chart

Happy Trading!!

The Scrutinizer